54 753 (Letrozole 2.5 mg)
Pill with imprint 54 753 is White, Round and has been identified as Letrozole 2.5 mg. It is supplied by Roxane Laboratories, Inc.
Letrozole is used in the treatment of breast cancer, metastatic; breast cancer, adjuvant; breast cancer and belongs to the drug classes aromatase inhibitors, hormones/antineoplastics. There is positive evidence of human fetal risk during pregnancy. Letrozole 2.5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 54 753
Letrozole
- Imprint
- 54 753
- Strength
- 2.5 mg
- Color
- White
- Size
- 6.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Aromatase inhibitors, Hormones/antineoplastics
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Roxane Laboratories, Inc
- National Drug Code (NDC)
- 00054-0269
- Inactive Ingredients
-
lactose anhydrous, microcrystalline cellulose, silicon dioxide, magnesium stearate, sodium starch glycolate type A potato, corn starch
Note: Inactive ingredients may vary.
Related Images for "54 753"
More about letrozole
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 228 Reviews
- Drug class: aromatase inhibitors
Consumer resources
Other brands: Femara
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
